Abstract
We sought to determine the cost-effectiveness of the recommendations of cardiologists for the pharmacologic treatment of hypercholesterolemia. Despite the publication of guidelines such as the report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, little is known about the national prescribing practices of physicians and how they compare with the recommendations of cost-effectiveness analyses. Under the auspices of the Cardiovascular Norms Committee of the American College of Cardiology, a nationally representative sample of cardiologists was surveyed, and their recommendations for the pharmacologic treatment of hypercholesterolemia were assessed to determine cost-effectiveness. The 346 responding cardiologists were reasonably representative of the membership of the American College of Cardiology. For the 12 hypothetical patients, the cardiologists recommended pharmacologic treatment more commonly in cases in which previously published studies estimated the treatment to be more cost-effective, although there was a tendency to recommend such treatment for primary prevention even when it was estimated to cost well over $100,000/year of life sa...Continue Reading
References
Dec 1, 1992·Archives of Internal Medicine·L A HeadrickR D Cebul
Sep 1, 1992·Circulation·S B HulleyT B Newman
Feb 15, 1992·BMJ : British Medical Journal·G Davey Smith, J Pekkanen
Jul 23, 1992·The New England Journal of Medicine·G A LamasE Braunwald
Mar 1, 1992·American Heart Journal·P E McBrideG Underbakke
May 1, 1992·Circulation·P E McBride, J E Davis
May 1, 1992·Circulation·L GoldmanM C Weinstein
Jul 1, 1992·Archives of Internal Medicine·S M Grundy
Jan 1, 1991·Health Affairs·A M Garber, J L Wagner
Apr 25, 1991·The American Journal of Cardiology·J W HayA M Gotto
Jun 11, 1991·Archives of Internal Medicine·A M GarberM Gluck
Feb 6, 1991·JAMA : the Journal of the American Medical Association·E L Barrett-ConnorS L Edelstein
Apr 1, 1991·Archives of Internal Medicine·B SchuckerB M Rifkind
May 1, 1991·The American Journal of Cardiology·G A ColditzW C Willett
Mar 1, 1991·Journal of General Internal Medicine·J M SchectmanB A Bartman
Jan 26, 1990·JAMA : the Journal of the American Medical Association·S B Soumerai, J Avorn
Aug 11, 1990·BMJ : British Medical Journal·M F MuldoonK A Matthews
Oct 1, 1988·The American Journal of Cardiology·L B Jorde, R R Williams
Jan 1, 1988·Archives of Internal Medicine
Dec 6, 1984·The New England Journal of Medicine·D U Himmelstein, S Woolhandler
Oct 1, 1984·Journal of the American College of Cardiology·S SheaA Nichols
Oct 9, 1993·Lancet·D Ketley, K L Woods
May 22, 1993·BMJ : British Medical Journal·M G Dunnigan
May 22, 1993·BMJ : British Medical Journal·G D SmithT A Sheldon
Citations
Mar 11, 2000·Disease-a-month : DM·P R Liebson, E A Amsterdam
Sep 17, 2009·Health Policy·C T Bolliger
May 5, 2009·Progress in Cardiovascular Diseases·Claudio Napoli, Francesco Cacciatore
Aug 28, 2002·Gastrointestinal Endoscopy·Shai FriedlandRoy M Soetikno
Dec 13, 2017·Expert Opinion on Drug Metabolism & Toxicology·Arrigo F G CiceroClaudio Borghi
Sep 17, 2013·PloS One·Penny BeeKathryn M Abel
Jun 17, 2016·Neurosurgery·Julio C FurlanMichael G Fehlings
Feb 28, 1998·Medizinische Klinik·K ObermannG C Mautner